Minovia Therapeutics Company
Minovia Therapeutics is a biotechnology research company focusing on treatment for mitochondrial disease. The company uses a cell therapy to treat such disease through its Mitochondrial Augmentation Therapy (MAT) platform. The company's platform repairs damaged mitochondrial DNA by using autologous stem cells enriched with blood-derived mitochondria.
Headquarters:
Israel
Funding Status:
N/A
Employee Number:
Undisclosed
Investment Stage:
N/A
Number Of Exists:
N/A
Technology:
N/A
Investor Type:
N/A
Founded Date:
2011
Industry:
Mitochondria Transfusion